PSME2 and prostate adenocarcinoma: Notably, we observed a negative correlation between PSME2 mRNA expression and methylation (Figure S5), and survival outcomes assessed by Kaplan-Meier curves showed that reduced methylation was predictive of shorter survival in ACC and PRAD (Figure S6A).